News Features Reimbursement Issues Seem to Be Holding Renal Denervation Back Todd Neale December 19, 2024
News Features Let’s Talk About Sex: How Best to Broach Post-MI Conversations Caitlin E. Cox June 14, 2024
News Features The Promise of Pulsed-Field Ablation: Cautious Optimism Amid Some Unknowns Todd Neale March 29, 2024
News Features ‘Ridiculous’ System Has Many Calling for an Interventional Cardiology Match Yael L. Maxwell October 19, 2022
News Features As US Abortion Protections Are Lost, Cardiologists Brace for Impact Todd Neale June 24, 2022
News Features ‘Band-Aid’ Approach to Fixing Cuts to Physician Reimbursement Needs Rethink Yael L. Maxwell March 30, 2022
News Features World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard Shelley Wood December 13, 2021
News Features Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay? Todd Neale December 09, 2021
News Features The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive Todd Neale February 08, 2021
News Features From Heroes to Humans: How Doctors Found Their Voices in 2020 Caitlin E. Cox December 21, 2020
News Features As US Cardiologists Mull a Biden Presidency, COVID-19 Trumps All Todd Neale November 13, 2020
News Features Obesity and COVID-19: Theories and Blame Fill the Scientific Void Shelley Wood April 21, 2020
News Features ‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry Michael O'Riordan January 10, 2020
News Features Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses Shelley Wood December 23, 2019
News Features Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019 L.A. McKeown December 12, 2019
News Features Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019 Todd Neale December 10, 2019
News Features Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis? Michael O'Riordan February 01, 2019